Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
166.7 USD | +1.10% | -0.27% | -7.34% |
May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
Financials (USD)
Sales 2024 * | 638M | Sales 2025 * | 740M | Capitalization | 9.21B |
---|---|---|---|---|---|
Net income 2024 * | 45M | Net income 2025 * | 88M | EV / Sales 2024 * | 14 x |
Net cash position 2024 * | 284M | Net cash position 2025 * | 420M | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
282
x | P/E ratio 2025 * |
111
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.42% |
Latest transcript on Repligen Corporation
1 day | -0.37% | ||
1 week | -0.85% | ||
Current month | +0.42% | ||
1 month | -9.36% | ||
3 months | -19.57% | ||
6 months | +12.18% | ||
Current year | -8.29% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 166.5 | +0.98% | 232 174 |
24-05-09 | 164.9 | -0.37% | 419,611 |
24-05-08 | 165.5 | -1.32% | 323,889 |
24-05-07 | 167.7 | -0.19% | 529,350 |
24-05-06 | 168 | +0.59% | 458,055 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.29% | 9.21B | |
-4.91% | 182B | |
+0.46% | 110B | |
-3.62% | 67.92B | |
+3.26% | 50.96B | |
+9.11% | 44.7B | |
+2.70% | 40.66B | |
+6.39% | 27.6B | |
+3.83% | 26.63B | |
+13.67% | 24.84B |
- Stock Market
- Equities
- RGEN Stock